Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with insulin requiring type 1 or type 2 diabetes for at least 24 months
Current treatment with human insulin (either premix of short and long/intermediate acting insulin) in a twice daily treatment regimen preparation and/or self-mix for at least 12 months
Body mass index (BMI) below or equal to 35.0 kg/m\^2
HbA1c below or equal to 11.0%
You may not be if
Total daily insulin dose at least 1.4 IU/kg
Treatment with oral hypoglycaemic agents within the month prior to inclusion
Recurrent severe hypoglycaemia (as judged by the investigator)
Active proliferative retinopathy
Impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
